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Abstract: Background: Collagens of marine origin are applied increasingly as alternatives to
mammalian collagens in tissue engineering. The aim of the present study was to develop a
biphasic scaffold from exclusively marine collagens supporting both osteogenic and chondrogenic
differentiation and to find a suitable setup for in vitro chondrogenic and osteogenic differentiation
of human mesenchymal stroma cells (hMSC). Methods: Biphasic scaffolds from biomimetically
mineralized salmon collagen and fibrillized jellyfish collagen were fabricated by joint freeze-drying
and crosslinking. Different experiments were performed to analyze the influence of cell density
and TGF-β on osteogenic differentiation of the cells in the scaffolds. Gene expression analysis
and analysis of cartilage extracellular matrix components were performed and activity of alkaline
phosphatase was determined. Furthermore, histological sections of differentiated cells in the biphasic
scaffolds were analyzed. Results: Stable biphasic scaffolds from two different marine collagens were
prepared. An in vitro setup for osteochondral differentiation was developed involving (1) different
seeding densities in the phases; (2) additional application of alginate hydrogel in the chondral part;
(3) pre-differentiation and sequential seeding of the scaffolds and (4) osteochondral medium. Spatially
separated osteogenic and chondrogenic differentiation of hMSC was achieved in this setup, while
osteochondral medium in combination with the biphasic scaffolds alone was not sufficient to reach
this ambition. Conclusions: Biphasic, but monolithic scaffolds from exclusively marine collagens are
suitable for the development of osteochondral constructs.
Keywords: jellyfish collagen; mineralized salmon collagen; osteochondral tissue engineering;
biphasic scaffold; osteochondral medium; alginate
1. Introduction
Collagen is one of the most frequently applied biomaterials for biomedical research as well as
clinical applications [1,2]. The main industrial sources of collagen are bovine and porcine tissues;
however, there is increasing demand for alternative sources. Marine collagens which can be obtained
from both invertebrates and vertebrates [3,4] show promising features and have the potential to
overrule mammalian collagens in biomedical applications for several reasons. Marine collagens
do not bear the risk of disease translation and are not allergy-causing; they are not subjected to
ethical or religious concerns, show low inflammatory response and can be obtained with high
yield [1]. From the beginning of the 21st century research on marine collagens has continuously
emerged [5,6]. Scaffolds for tissue engineering applications are increasingly developed from collagens
of marine origin, such as from fish collagen, collagen of marine sponges, jellyfish collagen and
collagen from marine gastropods [5]. In two own studies we applied marine collagens for the
fabrication of porous scaffolds: first we adapted the procedure of biomimetic mineralization of bovine
collagen to collagen of the Atlantic salmon Salmo salar and prepared mineralized porous scaffolds
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from salmon collagen for the application in bone tissue engineering [7]. A second study applied
collagen of the jellyfish Rhopilema esculentum which is structurally similar to human collagen II [8]
for the preparation of porous scaffolds to be used for chondral tissue engineering [9]. In the present
study, we combined fibrillized jellyfish collagen with biomimetically mineralized salmon collagen
to a biphasic scaffold suitable for osteochondral defect regeneration. The applied technique was
already described in 2007 for the generation of biphasic, but monolithic scaffolds from mineralized
bovine tendon collagen and fibrillized collagen from calf skin/hyaluronic acid composite [10]. Joint
freeze-drying and chemical crosslinking of the two different phases resulted in a scaffold material
which overcame the risk of delamination of the mineralized and non-mineralized phases, since the
scaffolds consisted of a unified whole [10]. Challenge in the fabrication of biphasic scaffolds for the
regeneration of both cartilage and the subchondral bone layer is the mechanically stable conjunction
of the different phases, which have different mechanical properties to mimic the chemical nature of
elastic, water-rich chondral ECM, and the stiff, mineralized bone ECM. The main challenge, however,
is the simultaneous chondrogenic and osteogenic differentiation, guided by the scaffold properties
which should recapitulate the native milieu of bone and cartilage development [11–14]. Furthermore,
when osteochondral tissue engineering constructs are differentiated in vitro, a suitable osteochondral
medium should be developed [15,16]. The aim of the present study was to generate biphasic, but
monolithic porous scaffolds from fibrillized jellyfish collagen for the chondral part and biomimetically
mineralized salmon collagen for the bony part. Multipotent human mesenchymal stromal cells (hMSC)
were differentiated simultaneously into chondrocytes and osteoblasts, respectively, in this biphasic
scaffold in vitro. To generate a microenvironment, which guides the cells to the two differentiation
lineages, we inserted the cells into the chondral part with a tenfold higher cell density compared to the
bony part and, furthermore, used an alginate hydrogel for embedding the cells in the porous chondral
part. Furthermore, an osteochondral medium was developed and sequential seeding of the scaffold
phases with pre-differentiated MSC was performed.
2. Results
2.1. Preparation and Characterization of Biphasic Scaffolds from Marine Collagen
Biphasic, but monolithic scaffolds, composed of biomimetically mineralized salmon collagen [7]
and fibrillized jellyfish collagen [9] were successfully obtained by overlaying the two different phases
as liquid suspensions, joint freeze-drying and crosslinking. Figure 1 shows the morphology of these
scaffolds, both in dry and wet state. Although the stronger swelling of the jellyfish collagen phase is
clearly visible, the stability of the whole scaffold is not affected by the different swelling behavior of
the phases. This becomes especially obvious, when the microstructure of the scaffolds is analyzed.
Interconnecting pores were verified in the transition zone between the two phases (Figure 2). Scanning
electron microscopy (SEM) images show the smooth surface of the non-mineralized jellyfish collagen
pore walls, as well as the rough morphology of the mineralized salmon collagen, which originates in
the presence of hydroxyapatite nanocrystals, decorating the surface (Figure 2).
2.2. Evaluation of Optimal Seeding Density for the Osteogenic Differentiation of hMSC
Single scaffolds from mineralized salmon collagen were seeded with hMSC at three different
densities, 2.4 × 105 cells/cm3, 6 × 105 cells/cm3, and 1.2 × 106 cells/cm3 and cultivated under
osteogenic stimulation for 14 and 28 days. Number of viable cells, visualized by MTT staining
(Figure 3a) was still highest in the scaffolds with the highest initial seeding density after 28 days of
osteogenic stimulation. Quantitative analysis of cell number (Figure 3b) confirmed these findings.
Furthermore, it was shown, that cell number did not increase between d14 and d28 of cultivation.
Osteogenic differentiation was evaluated by quantification of specific alkaline phosphatase (ALP)
activity (Figure 3c). Highest specific ALP activities were obtained for the constructs with the lowest
seeding density; however, due to high variations between single samples the effect was not statistically
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significant. Furthermore, the ALP activity in scaffolds seeded with the lowest cell density was close
to the detection limit of the colorimetric test. Therefore, for the seeding of biphasic scaffolds, the
intermediate cell density (6 × 105 cells/cm3) was chosen, since specific ALP activity was still higher
compared to the highest seeding density.
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Figure 1. Biphasic scaffolds from mineralized salmon collagen (lower layer) and fibrillized jellyfish
collagen (upper layer) in dry state (a) as well in wet state (b). Arrows indicate the transition zone
between the layers. Scale bar represents 5 mm.
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2.3. Influence of TGF-β on Osteogenic Differentiation 
We tested the influence of TGF-β3 on the osteogenic differentiation of hMSC, seeded in 
monophasic scaffolds from mineralized salmon collagen. Specific ALP activity after 14 days of 
osteogenic stimulation showed a significant (p < 0.05) decrease in the presence of TGF-β3 both for 
hMSC and osteogenically prestimulated hMSC (Figure 4). The experiment was also performed to 
test the effectivity of osteogenic pre-stimulation in the monolayer, and a significantly (p < 0.001) 
higher specific ALP activity was detected both at day 1 and day 14. 
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Figure 3. (a) MTT staining of osteogenically ifferentiated hMSC seeded in mineralized salmon
collagen scaffolds at different densities and cultivated for 28 days; (b) cell number, calculated from
DNA content and (c) specific ALP activity (ALP activity related to cell number) of osteogenically
differentiated hMSC in salmon collagen scaffolds with different seeding densities after 14 and 28 days
of cultivati n, n = 3, mean +/− standard deviation. Significances from 2-way ANOVA were as follows:
Cell number: d14 ↔ d28 n.s.; 2.4 × 105 ↔ 6 × 105 n.s., 2.4 × 105 ↔ 1.2 × 106 p < 0.05; 6 × 105 ↔
1.2 × 106 p < 0.05, specific ALP activity: d14 ↔ d28 n.s.; 2.4 × * 105 ↔ 6 × * 105 n.s., 2.4 × 105 ↔
1.2 × 106 p < 0.05; 6 × 105 ↔ 1.2 × 106 n.s.
2.3. Influence of TGF-β on Osteogenic Differentiation
We tested the influence of TGF-β3 on the osteogenic differentiation of hMSC, seeded in
monophasic scaffolds from mineralized salmon collagen. Specific ALP activity after 14 days of
osteogenic stimulation showed a significant (p < 0.05) decrease in the presence of TGF-β3 both for
hMSC and osteogenically prestimulated hMSC (Figure 4). The experiment was also performed to test
the effectivity of osteogenic pre-stimulation in the monolayer, and a significantly (p < 0.001) higher
specific ALP activity was detected both at day 1 and day 14.
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mineralized salmon collagen under osteogenic stimulation (10−7 M Dex, 10 mM β-GP, 12.5 µg/mL
AAP = osteogenic supplements, OS+) in the presence and absence of 10 ng/mL TGF-β3. Dark bars:
cells were prestimulated with OS+ in monolayer culture for 9 days before seeding the scaffolds. Cells
of two different donors were used, each n = 3 per condition. ALP activity was related to cell number.
Values are presented as mean (n = 6) +/− standard deviation. Significances from 2-way ANOVA were
as follows: d1↔ d14 p < 0.001; d1↔ d14TGFβ p < 0.05; d14↔ d14TGFβ p < 0.05; non-differentiated↔
pre-differentiated p < 0.001.
Mar. Drugs 2018, 16, 91 5 of 16
2.4. Chondrogenic and Osteogenic Differentiation of hMSC in Biphasic Marine Scaffolds
A sequential seeding procedure for the biphasic collagen scaffolds was performed (Figure 5). In
the first step of sequential cultivation, hMSC were suspended in alginate solution, the jellyfish collagen
phase of the biphasic scaffolds was infiltrated with this mixture with a cell density of 6 × 106 cells/cm3
and the constructs were cultivated with complete chondrogenic medium for 9 to 12 days. At the same
time, hMSC from the same batch were seeded into flasks and cultivated in the presence of osteogenic
medium for 9 to 12 days. After 9 to 12 days of pre-stimulation, the osteogenically induced cells were
seeded into the mineralized salmon collagen layer of the biphasic scaffolds with an initial cell density of
6 × 105 cells/cm3. The constructs were cultivated until d21 from the initial seeding with osteochondral
medium, containing 5 ng/mL TGF-β3, ITS, 10−7 M Dex and 50 µg/mL AAP.
The biphasic constructs were stable during the whole cultivation period. MTT staining of viable
cells after 1 and 9 days of cultivation demonstrated that the chondrogenically induced cells did not
migrate out of the jellyfish collagen/alginate phase to the mineralized salmon collagen phase below
(Figure 6). This was confirmed by confocal laser scanning microscopic (cSM) investigations at the area
between the two phases (Figure 7).
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Figure 5. Pre-diff rentiation and sequential seeding of hMSC onto biphasic scaffolds from jellyfish
collagen and mineralized salmon collagen.
At the end of the cultivation, a contraction of the biphasic scaffolds was visible. This contraction
has been observed before in monophasic collagen scaffolds and it has been shown to be diminished
with the application of alginate as cell carrier. Histological sections of biphasic scaffolds after 21 days
of cultivation showed the presence of cells in both phases (Figure 8A–C). Furthermore, toluidine
blue staining of histological sections revealed the production of cartilage extracellular matrix in the
chondrogenic part of the scaffold (Figure 8D–F). The cellularity of the constructs is considerably lower
compared to pellet cultures of chondrogenically stimulated cells. However, we have shown in a
previous study, that higher cell densities in porous collagen scaffolds did not increase extracellular
matrix production per cell [9].
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Chondrogenic differentiation of the cells in the jellyfish collagen/alginate phase was verified by
gene expression analysis of collagen II, which was also detected at protein level (Figure 9).
Gene expression of collagen II increased from d1 to d12, but decreased slightly during the
cultivation of the biphasic constructs in the osteochondral medium. Similar results were obtained for
the quantification of collagen II by ELISA; however, there were always high variations between the
different samples (Figure 9b). Additionally, the production of sulfated glycosaminoglycans increased
during chondrogenic differentiation of jellyfish collagen/alginate embedded hMSC, but it did not
further increase during cultivation in the osteochondral medium (Figure 9c).
Osteogenic differentiation of hMSC in the mineralized salmon collagen phase was demonstrated
by ALP gene expression, which was strongest immediately after seeding of the biphasic scaffolds
with osteogenically pre-differentiated hMSC. During further cultivation in osteochondral medium
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the ALP gene expression decreased (Figure 9a). Furthermore, gene expression of osteocalcin was
analyzed in both scaffold parts, which was relatively low in all examined samples, however, cells in
the chondrogenic layer showed down-regulation of osteocalcin (Figure 9).Mar. Drugs 2017, 15, x FOR PEER REVIEW  7 of 17 
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Figure 8. Histological sections of biphasic scaffolds after 21 days of osteochondral cultivation:
Haematoxylin/Eosin staining of (A) jellyfish collagen phase, (B) mineralized salmon collagen phase
and (C) transition zone between jellyfish collagen part (top) and mineralized salmon collagen part
(bottom). Deeply purple stained regions in (B,C) represent mineralized salmon collagen which is
stained by haematoxylin too. Toluidine blue staining of (D) jellyfish collagen phase, (E) mineralized
salmon collagen phase and (F) transition zone between jellyfish collagen part (top) and mineralized
salmon collagen part (bottom).
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3. Discussion
Biphasic, but monolithic scaffolds, exclusively from the marine biopolymers jellyfish collagen,
biomimetically mineralized salmon collagen and alginate were fabricated for the first time. Due to
the concerted freeze drying of the two phases before crosslinking the layers were tightly connected
showing interconnecting pores through the area of the different layers. In the wet state, the two layers
showed different swelling behavior. While the biomimetically mineralized salmon collagen phase
did not swell, the volume of the fibrillized jellyfish collagen phase increased somewhat in wet state.
The reason for the different swelling behavior could be the difference between the collagen types.
Collagen II was shown to have higher swelling capacity compared to collagen I [17]. Furthermore,
the presence of nanocrystalline hydroxyapatite connected to the collagen fibers of the salmon collagen
could be responsible to the reduced swelling in this phase. Nevertheless, the different swelling behavior
did not impair the union between the two phases, which have been cross-linked with higher EDC
concentrations compared to the monophasic scaffolds. Despite the high concentration of carbodiimide
for crosslinking to allow the tight union between the phases, we did not detect any negative effects
on cytocompatibility. In a similar approach to our method mineralized and non-mineralized collagen
(from equine origin) were combined to a triphasic scaffold for osteochondral regeneration [18].
In contrast to our study, crosslinking of the single layers was performed before freeze-drying, which
required an additional knitting procedure to anchor the layers. Biphasic scaffolds from collagen I in the
chondrogenic part and collagen I mineralized with Mg2+ substituted hydroxyapatite in the osteogenic
part were recently prepared by Sartori and co-workers [19]. Also in this study, the collagen layers were
cross-linked before freeze-drying. Nevertheless, the resulting biphasic scaffolds were stable enough
to withstand subcutaneous implantation in mice for up to 8 weeks. In vitro investigations for MSC
differentiation, however, were only performed with monophasic scaffolds in this study.
For the generation of osteochondral tissue constructs in vitro progenitor cells like human
mesenchymal stroma cells need to be differentiated into two different lineages in spatially separated
phases of the same scaffold. Optimally, scaffold structure and chemical composition provide the
necessary stimuli for differentiation into the osteogenic and chondrogenic cell line. Jellyfish collagen
from R. esculentum has a similar structure to human collagen II, since it consists of α-chain homotrimers
and shows a degree of glycosylation similar to that of vertebrate collagen type II [20]. Chondrogenic
differentiation is triggered by clustering of hMSC, which can be realized by 3D pellet formation
or seeding of scaffolds with high cell densities [21]. Additionally, embedding of cells into alginate
hydrogel, infiltrated into porous collagen scaffolds, induced a chondrogenic phenotype and increased
collagen II expression of the cells [22]. Therefore, the upper (chondral) phase of the marine biphasic
scaffolds was seeded with hMSC in high density (6 × 106 cells/mL) which were incorporated into
alginate hydrogel completely filling the pores of the jellyfish collagen part of the scaffolds. Osteogenic
differentiation is favored by the presence of hydroxyapatite, and it has been shown in porous collagen
scaffolds in vitro, that specific ALP activity which is the main osteogenic marker increases with
decreasing seeding density [23]. Similar results were also obtained in the present study for monophasic
scaffolds from mineralized salmon collagen (Figure 3c). The lower phase of the biphasic marine
scaffolds was therefore seeded with hMSC in a tenfold lower density compared to the chondral part,
and the cells were allowed to attach directly at the pore walls of the mineralized salmon collagen
without addition of alginate. Nevertheless, as shown in our previous studies with monophasic scaffolds
from jellyfish collagen, scaffold structure and composition as well as cell density alone are not sufficient
to induce chondrogenic differentiation of hMSC. Likewise, biomimetically mineralized collagen
scaffolds, despite their bone-like composition of collagen and nanocrystalline hydroxyapatite, are not
osteoinductive. The addition of osteogenic stimuli is necessary to induce osteogenic differentiation of
MSC seeded in the scaffolds. For simultaneous osteogenic and chondrogenic differentiation of hMSC
in the marine biphasic scaffolds in vitro, a suitable osteochondral medium needed to be developed.
Cell culture media for the chondrogenic and osteogenic differentiation of MSC have equal and
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distinct components [24]. While dexamethasone and ascorbate are included in both chondrogenic and
osteogenic differentiation medium, both media have exclusive components (Table 1).
Table 1. Main differences in the composition of commonly used osteogenic and chondrogenic
differentiation media (FCS = fetal calf serum, ITS = insulin, selen, transferrin mix, AAP = ascorbic
acid-2-phosphate, Dex = dexamethasone, β-GP = β-glycerophosphate, TGF-β = transforming growth
factor β).
Osteogenic medium FCS - Low glucose AAP Dex β-GP
Chondrogenic medium - ITS High glucose AAP Dex - TGF-β
To develop an osteochondral medium supporting both osteogenic and chondrogenic
differentiation of MSC (additionally to the stimuli, which are exerted by the scaffold matrix) it
is not sufficient just to combine the single media 1:1. In a previous study we have analyzed the
impact of FCS on the chondrogenic differentiation of hMSC in monophasic scaffolds of jellyfish
collagen [25] and demonstrated, that even small amounts of FCS (2%) in the culture medium
significantly decrease the mRNA expression of chondrogenic markers. In addition, reduction
of glucose content caused a decreased mRNA expression of chondrogenic markers as well as a
decreased extracellular matrix production of the chondrogenically differentiated cells. In contrast,
osteogenic differentiation of hMSC in mineralized salmon collagen scaffolds was not affected when
the glucose concentration of the medium was increased (data not shown). Furthermore, osteogenic
differentiation of hMSC is even favored by low serum conditions (1% and 5% compared to 10%) [26].
B-glycerophosphate which is an integral component of osteogenic differentiation media to provide a
phosphate source for the mineralizing osteoblasts, is regarded as hypertrophy promoting reagent for
chondrocytes [27]. The main component of chondrogenic differentiation medium, TGF-β, was shown
to cause a downregulation of ALP expression [28], which was also found in our study for MSC seeded
in scaffolds from mineralized salmon collagen (Figure 4). Based on these results we propose an
osteochondral medium containing a reduced amount of TGF-β (5 ng/mL), no FCS, high glucose
content, bovine serum albumin, as well as the factors stimulating both osteogenic and chondrogenic
differentiation: dexamethasone and ascorbic acid-2-phosphate. However, even the combination of
(1) different seeding densities in the osteogenic and chondrogenic part (2) different scaffold layer
composition (3) alginate infiltration in the chondrogenic part preventing cell adhesion to the scaffolds
pores and therefore supporting chondrogenic cell phenotype and (4) osteochondral medium was
not sufficient to stimulate osteogenic and chondrogenic differentiation spatially separated in the
respective scaffold parts. Similar results were obtained by Gupta et al. who tried to simultaneously
differentiate rat MSC into chondrogenic and osteogenic lineage in gradient PLGA scaffolds with
encapsulated chondroitin sulfate for chondrogenic priming as well as tricalcium phosphate for
osteogenic priming [29]. The authors admittedly reported a better interaction of cells with the
materials and a greater cellularity, but it was not possible to drive differentiation specifically into either
of the planned directions. Caliari and Harley investigated the impact of scaffold local biophysical
properties like mineral content and density on hMSC differentiation in the presence of mixed soluble
signals for osteogenic and chondrogenic differentiation [30]. Unexpectedly, the authors observed an
increased osteogenic response just in nonmineralized scaffolds with low density, which were intended
to induce chondrogenic differentiation. Therefore, in the present study, a sequential seeding and
pre-differentiation approach was developed. It has been shown before, that temporal stimulation of
chondrogenic cells with TGF-β is sufficient to induce the chondrogenic phenotype in MSC. Buxton and
co-workers stimulated hMSC in hydrogels with TGF-β1 and demonstrated, that total production
of collagen II after three weeks of cultivation was not decreased in comparison to the controls,
when TGF-β was withdrawn after 7 days of prestimulation [31]. Likewise Fensky and co-workers
demonstrated, that a 10 day stimulation of hMSC embedded in a collagen I hydrogel is sufficient
to induce upregulation of the chondrogenic marker genes for collagen II and aggrecan after three
Mar. Drugs 2018, 16, 91 10 of 16
weeks of cultivation [32]. Short delivery of high TGF-β doses (100 ng/mL) for 7 days on bovine
MSC embedded in hyaluronic acid hydrogels was sufficient to induce and maintain the chondrogenic
phenotype over a period of 9 weeks [33]. Chondrogenically pre-differentiated hMSC maintained
their chondrogenic potential after embedding in methacrylated hyaluronic acid gels [34]. Osteogenic
pre-differentiation of MSC before application in bone regeneration has successfully been applied
by several groups. Peters et al. demonstrated that the injection of osteogenically pre-differentiated
MSC enhanced healing of a critical bone defect in rats [35]. It is hypothesized that the application
of osteogenically pre-differentiated instead of undifferentiated hMSC may prevent the transplanted
cells from neoplasia and tumor formation [36]. Osteogenic pre-differentiation of hMSC has been
successfully applied in our study. Osteogenically pre-differentiated hMSC seeded into monophasic
scaffolds from mineralized salmon collagen showed significantly increased ALP activity both at the
start of the 3D cultivation and after 14 days. Furthermore, the negative effect of TGF-β on ALP
activity is less pronounced for osteogenically pre-differentiated cells compared to non-differentiated
MSC, which is a further point to apply osteogenic pre-differentiation for osteochondral constructs.
Osteocalcin gene expression, which is a further marker of osteogenic differentiation, was quite low
in the biphasic scaffolds. This is in accordance to a fundamental study of Jaiswal and co-workers,
demonstrating that vitamin D3 is necessary to induce adequate osteocalcin expression in osteogenically
differentiated hMSC in vitro [37]. We refrained from adding vitamin D3 to the osteochondral medium
to preserve the chondrogenic phenotype in the chondral layer. However, it might be beneficial to
include vitamin D3 into the osteogenic pre-differentiation medium in future. In the present study,
osteogenic and chondrogenic pre-differentiation was performed simultaneously. While chondrogenic
pre-differentiation was realized already during cultivation of alginate-embedded hMSC in the jellyfish
collagen part of the biphasic scaffold, osteogenic pre-differentiation of hMSC of the same batch was
performed in the monolayer. Gene expression analysis revealed collagen II expression exclusively in
the chondral part of the scaffolds; however, there was a slight decrease in collagen II expression during
the cultivation with osteochondral medium in the presence of osteogenically pre-differentiated cells.
Likewise, collagen II production on protein level and production of sGAG were somewhat decreased
during co-culture (Figure 9). It has been demonstrated that continuous treatment of hMSC pellet
cultures with TGF-β provided significantly higher production of extracellular matrix and expression
of chondrogenic genes compared to short-time TGF-β supplementation of 3 and 10 days [38]. Possibly,
the reduced TGF-β supplementation during osteochondral cultivation was not sufficient to stabilize the
chondrogenic phenotype at the starting level. Similar observations were made for the osteogenic part.
Highest ALP expression was detected immediately after seeding of the biphasic scaffolds, followed by a
decrease of ALP expression during further osteochondral stimulation. Since ALP is an early osteogenic
marker, the decrease could also relate to further differentiation along the osteogenic lineage. However,
it has to be noted, that the applied osteochondral medium does not provide optimal conditions for
osteogenic differentiation. Nevertheless, the RNA amount isolated from the mineral part of the
biphasic scaffolds after 3 weeks of cultivation was not reduced compared to the start of 3D cultivation,
suggesting that the osteogenically pre-differentiated cells survived the osteochondral conditions with
serum deprivation. After three weeks of cultivation osteochondral constructs were obtained in vitro
with spatial separated expression of chondrogenic ECM and osteogenic differentiation.
4. Materials and Methods
4.1. Preparation of Biphasic Scaffolds
Biphasic but monolithic collagen scaffolds were prepared by overlaying suspensions of
biomimetically mineralized salmon collagen and fibrillized jellyfish collagen in the cavities of a 96-well
plate. Biomimetically mineralized collagen and fibrillized jellyfish collagen suspensions were prepared
as already published [7,9]. After freezing of the overlayed samples at 1 K/min to a final temperature of
−20 ◦C lyophilization was conducted for about 24 h (Alpha 1–2, Christ). For stabilization the scaffolds
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were cross-linked with a 30 g/L solution of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC)
hydrochloride in 80% v/v ethanol for 12 h. Subsequently, the scaffolds were rinsed thoroughly in
deionized water, 1% glycine solution, once again in water and finally freeze-dried.
4.2. Cultivation of hMSC
Bone marrow derived hMSC harvested from the iliac crest of two healthy donors were kindly
provided by the group of Prof. Martin Bornhäuser (Medical Clinic I, University Hospital Dresden).
Written informed consent from the donors was obtained for the use of these samples in research.
Cells were characterized as hMSC according to the criteria of the International Society of Cellular
Therapy [39]. All procedures were approved by the Ethical Commission of the Medical Faculty
of Technische Universität Dresden. Cells were expanded in Dulbecco′s modified Eagle′s Medium
(DMEM, Gibco) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin and
100 µg/mL streptomycin (all from Biochrom, Berlin, Germany) (expansion medium) until passage five.
General seeding preparation for porous collagen scaffolds: Scaffolds were immersed with
expansion medium for 24 h, which was removed before seeding wet scaffolds were placed on sterile
filter paper to remove excess immersion medium from the scaffold pores.
4.3. Osteogenic Differentiation of hMSC in Mineralized Salmon Collagen Scaffolds
Monophasic scaffolds from mineralized salmon collagen (d = 6 mm, h = 3 mm) were prepared as
already published [7] and sterilized by γ-irradiation before use in cell culture. Scaffolds were seeded
with 2 × 104, 5 × 104, and 1 × 105 cells in 50 µL of expansion medium. After 30 min of initial adhesion,
further 500 µL of expansion medium were added to each scaffold. Cell-seeded scaffolds were cultivated
for up to 4 weeks, with medium change every 3–4 days. Osteogenic differentiation medium contained
Minimal essential medium α-modification (α-MEM) (Biochrom Berlin, Germany), supplemented with
10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin (all from
Biochrom), 10−7 M Dex, 12.5 µg/mL AAP and 10 mM β-GP (all from Sigma, Taufkirchen, Germany).
Since we wanted to analyze the effect of TGF-β on the osteogenic differentiation additionally 10 ng/mL
TGF-β3 (Miltenyi, Bergisch Gladbach, Germany) were added to one experimental group. After 1, 14
and 28 days samples for DNA and ALP quantification were washed twice and frozen at −80 ◦C.
4.4. Cultivation of Osteochondral Constructs
Biphasic scaffolds from jellyfish collagen and mineralized salmon collagen (d = 6 mm, h = 8 mm)
were sterilized by γ-irradiation before use in cell culture. Sodium alginate (Sigma) was dissolved in
Ca2+ free DMEM (Sigma) without any further supplements at 12 mg/mL and the solution was filtered
through a syringe filter with 0.45 µm pore size. 5 × 105 cells were suspended in 50 µL of alginate
solution and the suspension was applied to the top of each biphasic scaffold. With 6 mm diameter
and 3 mm height the chondral phase of the biphasic scaffold has an approximate volume of 85 mm3
resulting in a seeding density of 6 × 106 cells/cm3. After 15 min of incubation at 37 ◦C, 1 mL of sterile
CaCl2 (100 mM) solution was added and the constructs were incubated for further 15 min for the
formation of alginate gel. The constructs were washed with expansion medium and cultivated further
with chondrogenic differentiation medium (DMEM high glucose (Gibco, Dublin, Ireland, distributed
by Thermo Fisher, Waltham, MA, USA), 100 U/mL penicillin, 100 µg/mL streptomycin, 1% ITS-X-Mix
(Gibco; results in concentrations of 10 µg/mL insulin, 5.5 µg/mL transferrin, 6.7 ng/mL sodium
selenite and 2 µg/mL ethanolamine in the medium), 0.35 µM proline, 50 µg/mL AAP, 10−7 M Dex,
0.15% bovine serum albumin (BSA) (all Sigma) and 10 ng/mL TGF-β3 (Miltenyi)) for 9–12 days with
medium changes every 3–4 days. At the same time, hMSC from the same batch were cultivated in
T-flasks with α-MEM supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin
and 100 µg/mL streptomycin, 10−7 M Dex, 12.5 µg/mL AAP and 10 mM βGP. After 9 to 12 days of
separate cultivation, biphasic scaffolds seeded with chondrogenically pre-differentiated hMSC were
gently dried on sterile filter paper, flipped, that the mineralized layer was on top of the scaffold and
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were seeded in the mineralized salmon collagen layer with 5 × 104 osteogenically pre-differentiated
hMSC in 50 µL cell culture medium, resulting in a seeding density of 6 × 105 cells/cm3. The constructs
were cultivated up to 21 days of total cultivation time with osteochondral medium consisting of
DMEM high glucose supplemented with 100 U/mL penicillin, 100 µg/mL streptomycin, 1% ITS-X-Mix,
5 ng/mL TGF-β3, 10−7 M Dex, 0.35 µM proline, 0.15% BSA and 50 µg/mL AAP. For each time point
of the experiment 9 biphasic scaffolds were used (3 for gene expression analysis, 3 for measurement of
collagenII and sGAG, 1 for MTT staining, 1 for fluorescence staining and 1 for histological staining).
4.5. MTT Staining
To detect the distribution and amount of viable cells, medium of cell-seeded monophasic and biphasic
scaffolds was supplemented with 1.2 mM 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT; Sigma), followed by further incubation at 37 ◦C for 4 h. Cell seeded scaffolds were
imaged using a Leica stereomicroscope.
4.6. Fluorescence Staining and Confocal Laser Scanning Microscopy
Cell-seeded scaffolds were fixed with 4% buffered formaldehyde and permeabilized with
0.2% Triton X-100 (Sigma) in Hank’s balanced salt solution (HBS) (Gibco). Autofluorescence was
blocked with, 30 min incubation in 3% BSA in HBS. Staining of cytoskeleton was performed with Alexa
Fluor 488 phalloidin and staining of the nuclei with 0.3 µM DAPI (4′,6-diamidino-2-phenylindole
dihydrochloride; both Invitrogen) in HBS. Samples were imaged using a confocal laser scanning
microscope LSM 510 (Zeiss, Jena, Germany) applying an excitation/emission wavelength of 405/461 nm
(diode laser) for DAPI and 488/519 nm (argon laser) for Alexa Fluor 488.
4.7. Gene Expression Analysis
Biphasic scaffolds were divided with a scalpel into the two phases prior to RNA extraction, for
which three samples of each experimental group were used. During the RNA isolation procedure, cell
lysates of the three samples of each group were pooled.
To dissolve the alginate in alginate-containing jellyfish collagen constructs, samples were mixed
thoroughly with 55 mM sodium citrate (Fluka, distributed by Sigma-Aldrich, Taufenkirchen, Germany)
with 0.9% sodium chloride (Sigma), in DEPC-water (Gibco), incubated at 37 ◦C for 45 min and
afterwards mixed thoroughly again. Cells in the supernatant were centrifuged at 3600 rpm for 10 min,
resuspended in PBS, and centrifuged again. Both the pellet and the collagen scaffold were treated with
lysis buffer from peqGOLD MicroSpin total RNA Kit (Peqlab, Erlangen, Germany). Lysates from the
pellets and scaffolds were pooled and RNA was extracted according to the manufacturer′s instructions
of the kit. To isolate RNA from the mineralized salmon collagen phase, cell seeded scaffolds were
treated with lysis buffer from the RNA kit directly.
For polymerase chain reaction (PCR) 200 ng per experimental condition were transcribed into
cDNA in a 20 µL reaction mixture containing 200 U of superscript II reverse transcriptase, 0.5 mM
dNTPs (both Invitrogen), 12.5 ng/µL random hexamers (Eurofins MWG Operon, Ebersberg, Germany)
and 40 U of RNase inhibitor RNase OUT (Invitrogen, Carlsbad, CA, USA). 1 µL cDNA in 20 µL
reaction mixtures containing specific primer pairs were used for amplification in PCR analysis to detect
transcripts of collagen I, collagen IIa, collagen X, ALPL and β-actin, respectively. Primer sequences
(Eurofins MWG Operon), annealing temperatures and amplicon sizes for each gene are summarized in
Table 2.
For analysis, PCR products were visualized in 2% agarose gels (Ultra PureTMAgarose, Invitrogen).
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Table 2. Primer and conditions for reverse transcriptase PCR.
Marker Bp Primer (Forward/Reverse) Buffer/±Enhancer Tannealing Amplification Cycles
β-Act 234 5
′-GGACTTCGAGCAAGAGATGG-3′
5′-AGCACTGTGTTGGCGTACAG-3′ buffer S/− 55
◦C 30x
Col 1 331 5
′-GGATGAGGAGACTGGCAAC-3′
5′-GAAGAAGAAATGGCAAAGAGAAAG-3′ buffer S/− 55
◦C 25x
Col 2 388 5
′-GAACATCACCTACCACTGCAAG-3′
5′-GCAGAGTCCTAGAGTGACTGAG-3′ buffer Y/+ 60
◦C 35x
Col 10 196 5
′-GCCCACTACCCAACACCAAGAC-3′




5′-ATTCTCTCGTTCACCGCCCAC-3′ buffer S/− 55
◦C 30x
OCN 177 5
′-CAA AGG TGC AGC CTT TGT GTC-3′
5′-TCA CAG TCC GGA TTG AGC TCA-3′ buffer S/− 55
◦C 35x
4.8. Analysis of DNA Content, ALP Activity in Monophasic Scaffolds from Mineralized Salmon Collagen
sGAG Content and Collagen II Content
Frozen cell-seeded scaffolds were homogenized in ice-cold PBS (2 × 10 s at 5900 rpm) using
a Precellys24 apparatus (Peqlab, Erlangen, Germany). After homogenization, 10% Triton X-100 in
PBS were added to a final concentration of 1% Triton-X-100 and the samples were incubated on ice
for 50 min. ALP activity and DNA content were analyzed from the same lysate. ALP activity was
analyzed by conversion of p-nitrophenyl phosphate (Sigma, 1 mg/mL), in 0.1 M diethanolamine
pH 9.8, 1% Triton X-100 and 1 mM MgCl2, to p-nitrophenol after 30 min of incubation at 37 ◦C and
absorption measurement at 405 nm (Infinite® M200 Pro, Tecan, Männedorf, Switzerland). DNA
content was quantified from the same lysate with Quantifluor dye (Promega, Madison, WI, USA) at an
excitation/emission wavelength of 485/535 nm. Cell number was calculated from DNA content of
defined cell numbers. ALP activity was related to the cell number of the respective sample.
4.9. sGAG Content and Collagen II Content in Biphasic Scaffolds
Biphasic scaffolds were divided with a scalpel into the two phases prior to freezing for subsequent
biochemical analyzes which included always three biphasic scaffolds per group. After thawing
of alginate-containing jellyfish collagen constructs, samples were covered with 500 µL of 55 mM
sodium citrate (Fluka) with 0.9% sodium chloride (Sigma), in deionized water, homogenized (1 × 10 s
at 5900 rpm, Precellys24, Peqlab) incubated at 37 ◦C for 30 min and afterwards mixed thoroughly
again. After thawing mineralized salmon collagen constructs, samples were covered with 450 µL PBS,
homogenized (2 × 10 s at 5900 rpm), 50 µL of 10% Triton X100 were added, and the mixture was
incubated for 30 min at 37 ◦C. All samples were centrifuged at 3600 rpm for 10 min. The supernatants
were used for collagen II ELISA, while the pellet was further processed for sGAG determination.
Collagen II ELISA was performed as already published [25]. Briefly, each 50 µL of the supernatants
was added to wells which were precoated with primary antibody (Mouse Anti-Chick Collagen II
Capture Antibody (clone 35; Chondrex, Redmont, WA, USA) diluted 1:500 in PBS). A calibration line
was established using human collagen II (Millipore) diluted in PBS with 3% normal goat serum (NGS;
Life Technologies, Carlsbad, CA, USA). Afterwards 50 µL of secondary antibody (Biotin-labeled
Detection Antibody (Mouse monoclonal anti-Type 2 Collagen (Chondrex)) diluted 1:100 in PBS
with 3% NGS) were added. Detection was performed with streptavidin-horseradish-peroxidase
(R&D Systems, Minneapolis, MN, USA) and 3,3′,5,5′-tetramethylbenzidin substrate-solution (Sigma).
Absorbance was assessed at 450 nm (reference 570 nm) in a microplate reader (Infinite® M200 Pro,
Tecan). Absorbance values from scaffolds without cells carried along during the experiments were
subtracted as correction factors.
sGAG content from the pellets was quantified as previously described [25]. Briefly, 1 mL of
papain digestion solution (containing 125 µg/mL papain, 5 mM EDTA (both from Sigma), 100 mM
Na2HPO4, and 5 mM cystein (both from Carl Roth, Karlsruhe, Germany) in deionized water) were
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added to each pellet. After incubation at 60 ◦C for 24 h. 50 µL of the digested solution were subjected
to a commercially available sGAG assay (Kamiya, Seattle, WA, USA) according to manufacturer′s
instructions. Absorbance was assessed at 610 nm (Infinite® M200 Pro, Tecan).
4.10. Histological Investigations on Biphasic Scaffolds
Biphasic scaffolds cultivated for 21 days under osteochondral stimulation were fixed with 4%
buffered formaldehyde, dehydrated and embedded in paraffin. 5 µm sections were cut and mounted to
cover slides. After deparaffinization, sections were stained with hematoxylin/eosin (H/E) to visualize
cell distribution and toluidine blue to visualize the production of cartilage proteoglycans. Stained
samples were images using a BZ-9000 (Biorevo) (Keyence, Neu-Isenburg, Germany) microscope.
4.11. Statistical Analysis
Statistical analyses for cell number and ALP activity were performed by two-way analysis of variance
(ANOVA). Post-hoc analysis was performed in all cases to determine multiple comparisons using the
Tukey method (Origin 9.1, OriginLab). Significance levels were set as p < 0.05, p < 0.01 and p < 0.001.
5. Conclusions
Biphasic, but monolithic scaffolds exclusively from marine collagens are stable under cell
culture conditions for up to three weeks without any delamination of the phases. We have tried
to simultaneously differentiate hMSC into osteogenic and chondrogenic lineage spatially separated
in the bone and cartilage layer of the marine scaffolds. However, the different chemical nature and
mineralization of the layers, as well as different seeding densities, and the application of alginate
hydrogel to embed the cells into the jellyfish collagen layer of the scaffold were not sufficient to
trigger the differentiation of hMSC adequately into the respective direction. We therefore propose a
sequential seeding of the biphasic scaffolds and pre-differentiation of the cells into both osteogenic
and chondrogenic lineage to obtain functional osteochondral constructs.
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